Top in ID: Resistant UTIs are common; US doubles monkeypox testing

A study showed that many patients who presented to the ED with complicated UTIs were resistant to commonly used oral antibiotics.

Healio spoke to Thomas P. Lodise, PharmD, PhD, about the implications of the findings. It was the top story in infectious disease last week.

Another top story was about the United States doubling its monkeypox testing capacity. The news came a week after the CDC announced that it was expanding access to vaccines to address the ongoing outbreak.

Read these and more top stories in infectious disease below:

UTI study finds high rates of resistance to common antibiotics

A study of nearly 150,000 patients who presented to the ED with complicated UTIs found many were resistant to commonly used oral antibiotics, according to findings published in Open Forum Infectious Disease. Read more.

US doubles monkeypox testing capacity

Monkeypox testing capacity in the United States will double, the CDC announced Wednesday. Read more.

Empiric gram-negative antibiotic use is ‘inexplicably variable’ from hospital to hospital

Empiric gram-negative antibiotic use varied significantly across the United States, with high inter-hospital variability, according to a recent study published in Clinical Infectious Diseases. Read more.

BioFire Global Fever Panel successfully detects common acute fever-causing pathogens

A 1-hour sample-to-answer, molecular device successfully detected common causative pathogens of acute febrile illness with high positive and negative percent agreement directly in whole blood, according to a recent study. Read more.

Rates of recommended baseline testing for patients initiating HIV care are ‘suboptimal’

The rates at which patients initiating HIV care receive recommended tests are “suboptimal,” but they were higher among those who initiated care at a Ryan White HIV/AIDS Program-funded facility, researchers found. Read more.